Operator of a virtual healthcare company intended to provide remote medical examinations so that physicians can check on
Operator of a virtual healthcare company intended to provide remote medical examinations so that physicians can check on patients remotely.
Monitoring Equipment📍 Netanya, IsraelFounded 2011
Current Valuation
$512M
as of 2022-Q4
PRIVATE
QL Price
$512M
0% vs last round
QuantLogix's current estimate for TytoCare, published 2026-09-27 — in line with the last disclosed round of $512M (2022-Q4).
Confidence
low
Basis
round anchored
What backs this price
Last disclosed round
$512M
2022-Q4
weight 0.07
How this price has held up
No round has priced for TytoCare since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-27 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, TytoCare, 2026-09-27 (b4c76b387bee0a32).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is TytoCare going public?
No. TytoCare is private and has not filed to go public. There is no S-1 on file.
What is TytoCare's valuation in 2026?
TytoCare is valued at $512M as of 2022-Q4, set by its Series D-3 ($55M, Oct 2022). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has TytoCare filed an S-1?
No public S-1 is on file for TytoCare.
Is TytoCare publicly traded — can you buy TytoCare stock?
No. TytoCare is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for TytoCare on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Founded
2011
HQ
Netanya, Israel
Employees
189
Last Round
Series D-3 — $55M (Oct 2022)
IPO Status
private
Fundraising Status
Series D-3 · $55M · 3y 11mo ago
private
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Series D-3
$55M
Oct 2022
—
$512M
Talent Signal
Hiring trend
▼ Hiring downtrend
-17% vs 2026-08
Open roles
5
via careers page
Product-build share
20%
engineering, research, product, design
Trajectory
strengthening
go-to-market push — Only 20% of open roles build product — hiring is concentrated in sales/marketing/ops (2 of 5 open roles are marketing).
Recent senior hire: 1 senior hire (CEO); open roles trending down.
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
Key Executive Moves
INAdam PellegriniCEO · 2026-08-27
From trusted-source news extraction (deep-enrich pipeline); dates approximate publication, not effective date.
Counted from TytoCare's live job board as of 2026-09-14; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
SoftwareHealth CareHome Health CareMachine LearningArtificial IntelligenceMedical Device
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2022-Q4. Refreshed quarterly.